Cd ‐ Jra ‐ 1 . 3 .
نویسنده
چکیده
The goal of Web service (WS) discovery is to select WSs that satisfy both the users’ functional and non functional requirements. Focusing on non functional requirements, a matchmaking algorithm usually takes place to verify if the quality offered by the WS provider overlaps the quality requested by the user. Since quality, in a provider perspective, is costly, a further step, a negotiation, should be performed to identify a mutually agreed quality level. In this work, we join previous work on a semantic-based quality definition model and WS negotiation, to provide a framework enabling semantic-aware automated WS negotiation. More specifically, OWL-Q, a semantic QoS-based WS description language, is extended with appropriate negotiation concepts and properties.
منابع مشابه
Etanercept therapy in children with juvenile rheumatoid arthritis.
Etanercept is an effective inhibitor of tumor necrosis factor that has shown a beneficial effect in patients with juvenile rheumatoid arthritis (JRA) that did not respond to other disease-modifying drugs. Here we report 3 patients with JRA who were refractory to traditional therapy; 1 with systemic JRA and 2 with polyarticular JRA. They received etanercept 0.4 mg/kg (maximum 25 mg) subcutaneous...
متن کاملMasticatory function in patients with juvenile rheumatoid arthritis.
PURPOSE Children with Juvenile Rheumatoid Arthritis (JRA) rarely report temporomandibular joint (TMJ) pain, which may be due to pain avoidance mechanisms resulting in compromised masticatory function. This study examined the relationship between self-report measures of pain and dysfunction and measures of chewing performance in 44 JRA children and 34 normal controls. METHODS The children were...
متن کاملTreatment with etanercept for patients with juvenile rheumatoid arthritis in Taiwan--a preliminary report.
Tumor necrosis factor (TNF) is a major inflammatory cytokine involved in the pathogenesis of juvenile rheumatoid arthritis (JRA). Etanercept, approved in the United States and in Europe for use in patients with rheumatoid arthritis (RA) and JRA, is an effective inhibitor of TNF that has been shown to provide rapid and sustained improvement in both diseases. Here we report the preliminary result...
متن کاملJuvenile Rheumatoid Arthritis (JRA)
While the long-term outlook of JRA varies with different forms of the disease, over 1/3 of children in general will have active disease that persists into their adult lives, while the remainder experience a remission by the time they reach adulthood. Moreover, 30-50% of patients experience significant limitations in daily functioning 10 years after the onset of their disease. For these reasons,...
متن کاملPathogenesis and clinical manifestations of juvenile rheumatoid arthritis
Juvenile rheumatoid arthritis (JRA) is the most common rheumatic childhood disease; its onset is before 16 years of age and it persists for at least 6 weeks. JRA encompasses a heterogeneous group of diseases that is classified according to 3 major presentations: oligoarthritis, polyarthritis, and systemic onset diseases. These presentations may originate from the same or different causes that i...
متن کامل